Search Within

Department of Medicine

Formats
  1. Journal Article (19590)
  2. Meeting Abstract (16038)
  3. Review (1149)
  4. Book Section (934)
  5. Editorial (607)
  6. Research Letter (314)
  7. Conference Paper (301)
  8. Guidelines (295)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22319)
  2. Hematologic Malignancies, Division of (13274)
  3. Center for Hematologic Malignancies (11058)
  4. GSK Faculty (10645)
  5. Survivorship Research (9329)
  6. Division of Subspecialty Medicine (7534)

More Groups

People
  1. Robert Motzer (1248)
  2. Howard Scher (1132)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (905)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1064)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4215)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2286)
  6. Nature Publishing Group (2110)

More Publishers

Results (39615)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • ASO Visual Abstract: Adjuvant cytotoxic chemotherapy may not be associated with a survival advantage for resected intrahepatic cholangiocarcinoma
    Miscellaneous

    Sharib, J.; Rhodin, K. E.; Liu, A.; McIntyre, S.; Bartholomew, A.; Masoud, S.; DeLaura, I.; Kemeny, N. E.; Cercek, A.; Harding, J. J.; more...
    Annals of Surgical Oncology (2025)

    Fulltext@MSK | Save
  • BTK inhibitors versus venetoclax as first- or second-line therapy in chronic lymphocytic leukemia/small lymphocytic lymphoma: A real-world evidence study
    Research Letter

    Roeker, L. E.; Han, Y.; Teschemaker, A.; Mato, A. R.; Thompson, M. C.
    American Journal of Hematology (2025)

    Fulltext@MSK | Save
  • Cell-free circulating tumor DNA for noninvasive molecular profiling among patients undergoing definitive chemoradiation for locally advanced lung cancer
    Research Letter

    Lebow, E. S.; Eichholz, J.; Boe, L.; Zhang, Z.; Kratochvil, L. B.; Gelblum, D. Y.; Simone, C. B. 2nd; Shepherd, A. F.; Iyengar, P.; Shin, J. Y.; more...
    Advances in Radiation Oncology (2025)

    Fulltext@MSK | Save
  • Local therapy for isolated central nervous system progression among patients receiving antibody-drug conjugate therapy
    Research Letter

    Lebow, E. S.; Eichholz, J.; Zhang, Z.; Toumbacaris, N.; Imber, B.; Chen, L.; LaPlant, Q.; Yamada, J.; Pike, L. R. G.; Modi, S.; more...
    Advances in Radiation Oncology (2025)

    Fulltext@MSK | Save
  • Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases
    Journal Article

    Mitchell, J.; Camacho, N.; Shea, P.; Stopsack, K. H.; Joseph, V.; Burren, O. S.; Dhindsa, R. S.; Nag, A.; Berchuck, J. E.; O'Neill, A.; more...
    Nature Communications (2025)

    Fulltext@MSK | Save
  • Severe toxicity, but long-term persistence of CAR T cells after immune checkpoint inhibitors in large B-cell lymphoma
    Research Letter

    Deschenes-Simard, X.; Pennisi, M.; Perales, M. A.; Shah, G. L.; Zelenetz, A. D.; Yahalom, J.; Imber, B. S.; Santomasso, B. D.; Dahi, P. B.
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • The effect of methylation on the let-7-BCL2L1-BCL2 axis and the potential use of hypomethylating and BH3 mimetic drugs in histiocytic neoplasms
    Correspondence

    Salmon-Divon, M.; Meyuchas, R.; Shpilberg, O.; Okon, E.; Benhamida, J.; Yabe, M.; Petrova-Drus, K.; Zvida-Bloch, T.; Basood, M.; Mazor, R.; more...
    Leukemia (2025)

    Fulltext@MSK | Save
  • Methodologic approach to defining comorbidities in a cohort of patients with cancer: An example in the optimal breast cancer chemotherapy dosing study
    Journal Article

    Wang, P.; O'Connell, K.; Bhimani, J.; Blinder, V.; Burganowski, R.; Ergas, I. J.; Gallagher, G. B.; Griggs, J. J.; Heon, N.; Kolevska, T.; more...
    JCO Clinical Cancer Informatics (2025)

    Fulltext@MSK | Save
  • Best practices for delivering neoadjuvant therapy in pancreatic ductal adenocarcinoma
    Journal Article

    Cloyd, J. M.; Sarna, A.; Arango, M. J.; Bates, S. E.; Bhutani, M. S.; Bloomston, M.; Chung, V.; Dotan, E.; Ferrone, C. R.; Gambino, P. F.; more...
    JAMA Surgery (2025)

    Fulltext@MSK | Save
  • Neoadjuvant exercise therapy in patients with prostate cancer - In reply
    Correspondence

    Jones, L. W.; Ehdaie, B.; Boutros, P. C.
    JAMA Oncology (2025)

    Fulltext@MSK | Save